Supernus Pharmaceuticals
SUPN
#4328
Rank
S$2.65 B
Marketcap
$48.02
Share price
-0.95%
Change (1 day)
23.98%
Change (1 year)

EPS for Supernus Pharmaceuticals (SUPN)

EPS in 2023 (TTM): $1.06

According to Supernus Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is $1.07. In 2022 the company made an earnings per share (EPS) of $1.53 an increase over its 2021 EPS that were of $1.38.

EPS history for Supernus Pharmaceuticals from 2011 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$1.06-30.94%
2022$1.5310.78%
2021$1.38-57.68%
2020$3.2712.09%
2019$2.910.47%
2018$2.9089.38%
2017$1.53-38.59%
2016$2.49534.48%
2015$0.39-211.54%
2014-$0.35-91.1%
2013-$3.9639.46%
2012-$2.84-69.27%
2011-$9.24

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$26.18 2,345.57%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.36 587.25%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.38 402.53%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.03 276.23%๐Ÿ‡บ๐Ÿ‡ธ USA
$19.09 1,682.95%๐Ÿ‡บ๐Ÿ‡ธ USA